BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 23737033)

  • 21. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
    Martins WP; Vieira AD; Figueiredo JB; Nastri CO
    Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009154. PubMed ID: 26148507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chinese herbal medicine for menopausal symptoms.
    Zhu X; Liew Y; Liu ZL
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009023. PubMed ID: 26976671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone for peri- and postmenopausal women.
    Somboonporn W; Davis S; Seif MW; Bell R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004509. PubMed ID: 16235365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relaxation for perimenopausal and postmenopausal symptoms.
    Saensak S; Vutyavanich T; Somboonporn W; Srisurapanont M
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD008582. PubMed ID: 25039019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise for vasomotor menopausal symptoms.
    Daley A; Stokes-Lampard H; Macarthur C
    Cochrane Database Syst Rev; 2011 May; (5):CD006108. PubMed ID: 21563149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
    Genazzani AR; Monteleone P; Giannini A; Simoncini T
    Hum Reprod Update; 2021 Oct; 27(6):1115-1150. PubMed ID: 34432008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical activity for women with breast cancer after adjuvant therapy.
    Lahart IM; Metsios GS; Nevill AM; Carmichael AR
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011292. PubMed ID: 29376559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
    Deng L; Wu T; Chen XY; Xie L; Yang J
    Cochrane Database Syst Rev; 2012 Oct; 10():CD005287. PubMed ID: 23076912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial interventions for men with prostate cancer.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.
    Weibel S; Jelting Y; Afshari A; Pace NL; Eberhart LH; Jokinen J; Artmann T; Kranke P
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011989. PubMed ID: 28407220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk-reducing medications for primary breast cancer: a network meta-analysis.
    Mocellin S; Goodwin A; Pasquali S
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012191. PubMed ID: 31032883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytoestrogens for menopausal vasomotor symptoms.
    Lethaby A; Marjoribanks J; Kronenberg F; Roberts H; Eden J; Brown J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001395. PubMed ID: 24323914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone receptor modulators for endometriosis.
    Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical interventions for symptomatic mild to moderate knee osteoarthritis.
    Palmer JS; Monk AP; Hopewell S; Bayliss LE; Jackson W; Beard DJ; Price AJ
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012128. PubMed ID: 31322289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hormone therapy on the ocular surface and intraocular pressure for postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Hao Y; Xiaodan J; Jiarui Y; Xuemin L
    Menopause; 2020 Aug; 27(8):929-940. PubMed ID: 32520901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.